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    This article is aimed to show how the hitherto unknown precursors of vitamin B6, nicotine, 
ricinine and anabasine are discovered. Though the pathways of their biosyntheses remain 
unknown, that of nicotinamide-coenzyme is revealed. The mechanism of biosynthesis of the 
pyridine ring is that the carbonyl group reacts with the amino group in the molecule and so forms 
the pyridine ring nonenzymatically. 
   Since there are many biochemically important substances which contain the 
pyridine ring, the present paper aims to summarize the present status of the biosynthetic 
mechanism of the pyridine ring. 
   Many pyridine derivatives appear to enjoy ubiquitous distribution in animals, plants 
and microorganisms. Pyridine, known as the simplest six-membered heterocyclic com-
pound containing nitrogen, is observed mostly in the distillation products of bone 





                                Fig. 1. Pyridine.




                              Fig. 2. Ethylallylamine. 
   Excepting the considerable slowness in the reaction, pyridine shows chemical 
behaviors similar to those of benzene ring in halogenation, nitration and sulfonation. 
   The pyridine ring is found in a specific group of alkaloids. The group includes 
nicotine, which exists in tobacco leaf in combination with malic and citric acids. 
Nicotnic acid is obtained by oxidation of nicotine. 
   Nicotinamide, the amide of nicotinic acid, is biologically important, because it 
is the active group of pyridine nucleotide coenzymes. 
-4JI3 
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                           H2C—CH2
                  H 
                 /~            HC/ I~ ------ HC~CH2 
                                     N—CH3 
              HCH 
                 Nicotine (Methyl pyrrolidine-pyridine) 
   HH 
               HC'
'~-000H HC11C\I-CONH2 
        HC\ ~CHHCCH    NN 
                   Nicotinic acid Nicotinamide 
                                      Fig. 3.
   Vitamin B6 is another important group of pyridine derivatives which includes 
pyridoxin, pyridoxal and pyridoxamine. These vitamins are growth factors for rats 
as well as for certain bacteria. 
      CH2OHCHOCH2NH2 
         HOC-CH2OH HO-C,CC-CH2OH HO-C- ''G-CH2OH 
       H3C- ,iHH3C-C~ICH113C-C~CI    N~N'N' 
           Pyridoxin Pyridoxal Pyridoxamine 
                                      Fig. 4. 
   Some of the aromatic compounds bearing the hydroxy groups are cloven by 
microbial enzymes and then the formation of the nucleus of pyridine follows. (See 
Chapter 5) 
   Pipecolic acid, baikiaine, quvacine, etc. are all natural six-membered heterocyclic 
compounds containing a nitrogen atom1). Although these compounds have no pyridine 
nucleus in their molecules, the mechanism of biosynthesis is quite similar to that of 
the pyridine derivatives. 
  H2HH C
~         H
2C/C,,CH2 HC'C~CH2 H2C 'C-COOH 
H2CCH000H 2C'NCHCOOH H2CNT~CH2 
HHH 
           Pipecolic acid Baikiaine Quvacine 
                                      Fig. 5. 
           1. Mechanism of the Formation of Pyridine Ring 
    Most of cyclization reactions are due to the reaction of carbonyl group >C=O, i.e. 
aldehyde and ketone. These cyclization reactions are widely used in chemical syntheses 
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as well as in biosyntheses of the heterocyclic compounds. The main feature that 
determines the reactivity of the carbonyl group is its polarization, symbolized as 
>C$+=08-. Thus there are two points of attack: a nucleophilic reagent will attack 
the electrophilic carbon atom, and an electrophilic reagent will attack the nucleophilic 
oxygen atom. In many cases, both processes occur. 
   Aldehydes and some of ketones react with amino compounds. There is a general 
type of reaction shown by the following equation: 
         RC= 0 + H2N—Y-----R,`C =N— Y1-H2O 
                                         Fig. 6. 
   In this case, the nucleophilic species, (—N—Y), reacts with the electrophilic carbon 
atom of the carbonyl group and the stable compound (>C=N—Y) is formed. 
   Two examples follow: 
 CH3CH3 
    HOOG_0H2NOH -----HOOCC=NOH +H2O 
        Pyru vate Hydroxylamine Oxime 
                                           Fig. 7. 
 it HH V\ 
C~ +H2N—NH—CONH2 C/+H20 
~N —NHCONH2 
       Furfural Semicarbazide Semicarbazone 
                                      Fig. 8. 
   A characteristic feature of these reactions is that there is an optimum pH (around the 
physiological pH); the rate increases on lowering the pH from 7 to about 5, and then 
the rate drops again as acidity of the solution increases2 . 
   Many cyclization reactions in this manner occur in the biological system. L-gluta-
mic ry-semialdehyde cyclizes to give .'-pyrroline-5'-carboxylic acid at physiological 
pH 3) 
   CHO N.H2 
    CH2 \~CCH    CH
H2C 
   CH2—l~ H2O 
CHNH2HC-- N 
   COOHCOOH 
               Glutamic r-semialdehyde Pyrroline-5- carboxylic acid 
                                      Fig. 9. 
   Most biosynthetic mechanisms of the pyridine ring seem to be the nonenzymatic re-
actions of the carbonyl and the amino group in the molecule'''). 
(290)
                       Biosynthesis of Pyridine Derivatives 
          2. Biosyntheis of Nicotinic acid and its Derivatives 
    Mammals and Neurospora are able to convert tryptophan into nicotinic acid via 
kynurenine,  3-hydroxyanthranilic acid and quinolinic acid. However, in bacteria the 
biosynthesis of nicotinic acid is accomplished by a different pathway. 
   Snell", Stanier'), and Yanofsky" reported that several bacteria could utlize 
neither tryptophan nor any of the intermediates in the tryptophan metabolism as a 
substitute for nicotinic acid as a growth factor. Ortega and Brown" investigated 
in an attempt to obtain evidence for the identity of the precursors of nicotinic acid in 
bacteria. The results suggested that the probable precursors of this vitamin in E. 
coli were a 4-carbon dicarboxylic acid and either glycerol or a compound to which glycerol 
could be easily converted. The evidence for this conclusion was provided by the 
finding that both succinic acid-C" and glycerol-C" were efficiently incorporated 
into the nicotinic acid molecule. Nicotinic acid, produced from glycerol-1,3-C" 
and non-radioactive succinic acid, appeared to contain C" only in the pyridine ring 
portion of the molecule. Nicotinic acid, produced from succinic acid-1,4-C" and non 
radioactive glycerol, contained C" in the carboxyl group. Nicotinic acid, produced 
from succinic acid-2,3-C" and non radioactive glycerol, was labeled largely in the 
pyridine ring. Since Andreoli et al.10) reported that quinolinic acid was a precursor 
to nicotinamide adenine dinucleotide (NAD) in E. coli, succinate and glycerol appeared 
to be possible precursors to quinolinic acid. 
CH2OFl 
cumH 
(                                                                                                  •                     COOH              cHzox—~~'~, 
COOH• 
*F12 - -c~Ni COOH •CH2 
• COOH 
                       Fig. 10. Biosynthesis of nicotinic acid 
                                 from glycerol and succinate. 
   NAD, (DPN), an important coenzyme of general utility, contains the heterocyclic 
bases, adenine and nicotniamide, and two molecules of D-ribose. The two component 
nucleotides are jointed by a pyrophosphate bridge. There is a related component, 
which is also widely distributed in the biosphere, and only differs from the above sub-
stance by having an additional phosphate residue which is esterified at C-2' of the ribose 
molecule of adenosine. This substance is known as NADP (TPNH). Reversible 
reduction of the pyridine ring transforms NAD into the reduced nucleotide NADH+ 
and similarly into NADPH+. 
   In mammals, the biosynthetic pathways of NAD from tryptophan or from nicotinic 
acid are established as follows: 
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-CH2—CH-000HCO—CH2—CHCOOH / COOH 
                          N                                                       NH2       H2                                             NH
2 N-- NH2 
   HOHOH 
                 TryptophanKynurenine3-Hydroxy anthranilic acid 
~1 COOHCOOH,''* COOH / I COOH 
         OHC 
        NHa~
N. COOH~N%N   COOH1 
Ribose-P Nicotinic acid 
                                                    Nicotinic acid 
                                           Fig. 11. mononucleotide 
          Tryptophan pyrrolase, the enzyme that converted tryptophan to formylkynurenine 
       was purified 35-fold from a Pseudomonas sp. by Tanaka and Knox11>. Recently, 
       Feigelson et al.12> showed that this enzyme was a heme-containing enzyme and cleared 
       its reaction mechanism. 
          The formation of the pyridine ring was elucidated by Mehler et al.13'14) 3-
       Hydroxyanthranilic acid is oxidized to 1-amino-4-formyl butadiene-1 :2 dicarboxylate. 
      The aldehyde group and amino group are rearranged, and quinolinic acid is non-
      enzymatically formed. Three groups of workers have purified 3-hydroxyanthranilic 
       acid oxidase extensively15'16,17) 
           In mammals19.20 as well as bacterial0) and plantsl3'19> quinolinic acid is shown to 
      be the universal intermediate in the biosynthesis of the pyridine ring compound, though 
       it arises by different pathways in different organisms. Nakamura et al.20) found the 
       quinolinate transphosphoribosylase and expained the mechanism of the formation 
       of niacin ribonucleotide through quinolinic acid. 
          The pathways of the formation of NAD are summarized in the following figure. 
r,COon 
                         .~/CH2TICONH2 \
-HtJ     GCoox~~coox ,i°CHxcN 
   '-JATP PPi 
                                  !RiboseN
`P=0HC---C H 
     \N~COON-.>L\N.',C.-4U>HOoOH OHNH2 
         Ribose / Ribose-P `Ribose-AdenineHCN~N 
      Quinolinic acid / Nicotinic acid0=P—O--CH2~~        mononucleotide / mononucleotideDeamido NAD-CHH~C-N~N~ 
         ATP rATPOHHj~I/~H 
CooHOH OH 
                                                                     NAD
ATP'N>            PRPP 11
           Ribose' CONH
2 
tl                                             \N/ '' ~ ~---)CONHz 





            acidFig. 12. 
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    Nicotinic acid appears to be the direct precursor to NAD, and nicotinamide is not 
involved in this reaction. Imsande and  Handler") have made a detailed study of 
the enzymes that convert nicotinic acid and 5-phosphoribosyl-1-pyrophosphate into 
deamido-NMN and PPi. They found that Mg++ was necessary and that ATP stimulat-
ed this reaction. They have also investigated the regulatory mechanism of pyridine 
nucleotide biosynthesis in R. coli 22). 
          3. Biosynthesis of Nicotine, Ricine and Anabasine 
    The biosynthetic pathways of nicotine, ricinine and anabasine are not clear yet. 
In order to elucidate the biosynthetic pathway of nicotine, several tracer experiments 
in vivo have been made with Nicotiana rustica23>. Both glycerol-2-C" and aspartic-3- 
C" were shown to be incorporated into the pyridine ring, whereas propionate-3-C" was 
not. Glycerol-2-C" was incorporated into the pyridine ring to about the same extent 
as glycerol-1,3-C". Partial degradation of the pyridine ring of nicotine from plants 
which were fed aspartic acid-3-C", revealed that aspartic acid was not converted directly 
to the ring, since C" was located in more than a single position in the pyridine ring23,24). 
    Ricinine (N'-methyl-3-cyano-4-methoxy-2-pyridone), is an alkaloid which is 
produced in the castor plant, Ricinus communis L. It has been shown to be risen from 
nicotinic acid-7-C" 26). The carbon 14 was located in the cyano group. Studies on 
the incorporation of succinate, propionate, acetate, glycerol and (S-alanine showed the 
following order of efficiency as precursors of ricinine: succinate, propionate, ,8-alanine. 
Acetate and glycerol were incorporated into the pyridine compounds approximately to 
the same extent. All of the radioactivity in ricinine produced in the presence of suc-
cinate-2,3-C" was found in the pyridine ring. The radioactivity in the alkaloid formed 
in the presence of succinate-1,4-C" was located 75 % in the pyridine ring and 25 
% in the cyano group. 
    When glycerol-2-C" was administered to Nicotiana glauca plants, the radioactive 
anabasine produced, had 38 % of the original radioactivity located in the pyridine 
ring26'"). In addition, anabasine derived from glycerol-2-C" was found to have sub-
stantial activity at C-2, C-3 and C-5, but only low activity at C-4 and C-6. These 
results were consistent with the hypothesis that nicotinic acid, the precursor of the 
pyridine ring of anabasine, was formed from glycerol and succinate or closely related 
metabolites in Nicotiana species. 
                    4. Biosynthesis of Vitamin B6 
   This vitamin is a component of the vitamin B complex and cures acrodynia (a 
pellagra like dermatitis) in rat and deficiency dermatitis in other animals. The struc-
ture of vitamin B6 is 2-methyl-3-hydroxy-4,5-bis(hydroxymethyl) pyridine and this is 
given the trivial name pyridoxin. Snell and Guirard23> discovered two closely related 
compounds during their work on the role of pyridoxin in microbial nutrition; these 
are the corresponding aldehyde, (pyridoxal) and the amine, (pyridoxamine). The 
main metabolically active form of these compounds is pyridoxal phosphate, which is a 
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coenzyme for amino acid decarboxylase, transaminase, racemase, etc. Pyridoxamine 
phosphate can act as the coenzyme for transaminase. 
    CHOCH2 NH2   O
O 
       HOC~CH2OPOHHOC~' -CH2 O--P —OH II 
    H3CC NCH OHH3CCCH OH 
             Pyridoxal phosphatepyridoxamine phosphate 
                                      Fig. 13. 
   Little is known about B6 synthesis in bacteria. It was considered for some time 
that D-alanine, which plays the role of pyridoxin in the nutritional requirement of 
certain Lactobacilli, might be a precursor of this vitamin29). But it was later revealed 
that pyridoxin was concerned with the synthesis of D-alanine which was an essential 
component of the cell wall of many bacteria30'31). By testing the effects on growth of 
varying ingredients of the media, Wood and Morris"") concluded that serine, glycine 
and glycolaldehyde were possible precursors in the biosynthesis of B, in F. coll. How-
ever, no isotope experiment has been performed to confirm the hypothesis. 
   Lunan and West3A" isolated the C"- labeled pyridoxamine from Candida utilis. 
Serine-.3-C'4, alanine-1-C14, acetate-1-C" and acetate-2-C" gave rise to C" labeled 
pyridoxamine. But the observed extents of incorporation were too low to permit a 
definitive interpretation cf these results in terms of the biosynthesis of vitamin B6. 
   The author isolated two strains of B6 biosynthesizing bacteria from soil. One strain 
of them belongs to Klebsiella and the other belongs to Flavobacterium36'38> The pro-
duction of B6 by resting cells of these bacteria was increased by the addition of glycerol, 
and either L-leucine or L-aspartic acid. Maximal synthesis was achieved in the pre-
sence of glycerol and leucine or glycerol and aspartic acid. The carbon chains of both 
glycerol-C14 and leucine-U-C14 were efficiently incorporated into newly synthesized 
pyridoxal by the resting cells, while the radioactivity of leucine-1-C14 was not. B6, 
which was produced by cells incubated with glycerol-2-C14 and non radioactive aspartic 
acid, was labeled largely in the pyridine ring. From these results it may be concluded 
that in the bacteria, B6 is probably derived from a 3-carbon compound (either glycerol 
or a compound related metabolically to glycerol), and from a 4-carbon compound 
which is related metabolically to leucine or aspartic acid (for instance, fi-hydroxy-/3-
methyl-glutaryl CoA), and also is concluded that these compounds will react with 
NH4 ion resulting in the formation of the pyridine ring9''38,3" 
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CH3 CH3CH3 CH3CH3 CH3CH3 CH3 
 \
GHCH\\/          GHn 
    CH3_~CH2 --CoACHO_CHO 
CHNH2 ----C=0..-_—        SS 
  COOHCOOHCoACoA 
     Leucinea-KetoIsovaleryl-CoA Senecioyl 
            isocaproic acid-CoA 
CH3 CH3COOH 
   COHCH2CH3             1CH3             I 
CH2CH3—C—OHC=01 
ICH2CH2+ I 
C= 0 -.-_r. C= 0 _- COOHS 
 SSCoA 
    CoACoA 
j9-Hydroxy ii-Hydroxy-(l-methyl- Acetoacetic acid Acetyl-
     isovaleryl-CoA glutaryl- CoACoA 
                       Fig. 14. Metabolicpathway of leucine. 
   Although pyridoxin is nutritionally active for animals and some microorganisms, 
it is metabolically inactive as a coenzyme. Enzymatic phosphorylation must occur 
prior to its utilization. Pyridoxal kinase, the enzyme, which catalyzes the phosphory-
lation of pyridoxal, has been demonstrated in Streptococcus faecalis40J, Esclzerichia coli 
and yeast41), liver42'13), brain"), kidney and muscle45" ). All .the enzymes carry out 
the same reaction: 
                   PAL +ATP =PALP +ADP 
      5. The Formation of the Nucleus of Pyridine as a Consequence 
         of Oxidation of Benzene") 
   The cell-free extract of Pseudoinonas oxidizes one mole of protocatechuate (I) with 
uptake of one mole of oxygen and produces a white, crystalline, dibasic acid, 2,4-luti-
dinic acid (IV)"). The initial product (II) formed from protocatechuate has a maxi 
mum absorption spectrum at 410 m,u. When, however, dilute ammonia is used, this 
yellow color vanishes within a few minutes and a new compound (IV) is formed with 
spectrographic and chromatographic properties that are identical with those of 2,4-luti-
dinic acid. It is clear that this compound is formed by a nonenzymic reaction between 
a-hydroxy-y-carboxy muconic semialdehyde (II), the initial product of ring fission, 
and the ammonium ion presenting in the enzyme solution"9.5°) 
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H2 +NH3                                                       -2H20 HOOC-%"•••OH HOOCroH HOOCC~ iHOOC COOH 
    OHCOOHCOOHnonN 
             CHOCHO enzymic 
 \/ 
    Protocatechurica-Hydroxy g-carboxymuconic 2,4-Lutidinic 
    acid (I)semialdehydeacid (IV) 
                       (enol form) (II) (keto form) (III) 
                                      Fig. 15. 
   The cell-free extract of a strain of gram-negative bacterium oxidizes one mole of 
catechol (V) with uptake of one mole of oxygen. During the reaction a transient yellow 
color (VI) is produced, whose peak appears at 373 mu in neutral or alkaline solution. 
a-picolinic acid (VIII) is formed after being stood with a-hydroxymuconic semialdehyde 
(VI) and ammonium hydroxide for two days at room temperature. 
+NH3 
                         H2 -2H2O 
                        OH          CCOOH   \OHO~C=0I 
       OHCOOHCOOH . nonN 
            CHOCHO enzymic 
a-Hydroxy muconic 
    Catechol semialdehyde/a-Picolinic acid 
    (V) [enol form] /(VIII)                                   nonenzymic 
       COOH(VI)COOH 
     NHz02 }NH2 
OHliverCOOH        •i enzyme CHO 
                               s
s 
      3-Hydroxy(X) 
           anthranilic acid 
          (IX) 
                                      Fig. 16. 
   Recently Kita and Senoh") isolated new pyridine derivatives from p-hydroxy-
phenyl acetate (XI) and identified the products as picolinic-5-acetate (XIV) and picoli-
nic-4-acetate (XVI). The cell-free extract of Pseudomonas ovali attacks p-hydroxy-
phenyl acetate and the resulting products (XIII, XV) form pyridine rings in the am-
monium-acetate solution after being stood at room temperature for four hours. 
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              OHCOOH 
                            COOH  NH3 N 
                                    CHO 
   OHOH CH2OOOH CH2OOOH 
/ 10H (XIII) (XIV) 
CH2OOOH CH2OOOH HOOCN 
p HydroxyphenylOH NH3 COOH 
     acetic acid3,4 Dihydroxy phenyl CHO                     acetic acid 
(XI)(XII) 
CH2OOOH CH2OOOH 
                  (XV) (XVI) 
                                     Fig. 17. 
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